BeStock  
Stocks › Biotechnology › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2154Biotechnology
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings5.5x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average -12.1x

#238 of 2994 stocks by PE (1 = cheapest)

Price / book3.1x
CheapRich

Around its usual level · 50th percentile, 5-year average 3.8x

#3791 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-29x-16x-4x8xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$41.85
Price vs. fair value-4.7%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.08 – 3.78 50% (pricier than usual) #3791 of 5331 (1 = cheapest)
PE 5.48 -23.66 -12.08 100% (pricier than usual) #238 of 2994 (1 = cheapest)
PS – 31.35 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on EWTX.

Sign in to join the discussion.

Scroll to Top